To reiterate, evaluation of the activity of OXPHOS complexes showed higher levels in BRAF-mutated and BRAF/NRAS wild-type melanoma cell lines compared to HDFs, most likely due to a higher mitochondrial mass as indicated by VDAC1 immunostaining and activity of citrate synthase. This evidence concerns the gene NRAS and melanoma.